Contact this trialFirst, we need to learn more about you.
Arsenic-containing Agent
Tretinoin + Arsenic Trioxide (+/- Gemtuzumab) for Leukemia
Recruiting1 awardPhase 2
The Woodlands, Texas
This trial is studying giving tretinoin and arsenic trioxide with or without gemtuzumab ozogamicin to patients with acute promyelocytic leukemia that has not been previously treated.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.